Related Experiment Video
Updated: May 30, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Simple synthetic toll-like receptor 2 ligands
Abu-Baker M Abdel-Aal1, Kalifa Al-Isae, Mehfuz Zaman
1School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia.
Researchers synthesized simple toll-like receptor 2 (TLR2) ligands with minimal structure, featuring two long lipid chains. These compounds exhibit potent agonistic activity at nanomolar concentrations, offering potential for immune disorder therapies.
Area of Science:
- Immunology
- Medicinal Chemistry
Background:
- Toll-like receptor 2 (TLR2) activation by bacterial lipoproteins triggers innate and adaptive immune responses.
- Synthetic TLR2 agonists and antagonists are valuable for managing infectious and immunologic diseases.
Purpose of the Study:
- To synthesize and characterize novel, simple TLR2 ligands.
- To evaluate the TLR2 agonistic activity of these minimal structure ligands.
Main Methods:
- Chemical synthesis of two novel compounds featuring two long lipid chains.
- In vitro assessment of TLR2 agonistic activity.
Main Results:
- The synthesized compounds possess minimal structural requirements for TLR2 activity.
- Both ligands demonstrated potent agonistic activity at nanomolar concentrations.
Conclusions:
- The study identified simple TLR2 agonists with high potency.
- These findings contribute to the development of new therapeutics targeting TLR2-mediated immune responses.
More Related Videos
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Related Concept Videos
Formation of Lipopolysaccharides
Signal Transduction: Overview
Typically, signal transduction involves three...
Receptor Tyrosine Kinases
Selectins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Types of Signaling Molecules